Las Noticias News & Media

03 June 2022

Prime Biosciences signs distribution agreement with Calmark Sweden AB

 

Prime Biosciences PC announces that has entered into an exclusive distribution agreement with Calmark Sweden AB (publ) for their innovative Neo Platform.

Prime Biosciences signs distribution agreement with Calmark Sweden AB
READ MORE
24 February 2022

Prime Biosciences participated in the Panhellenic Conference for the 90 years of the Hellenic Society for Microbiology

 

The Panhellenic Conference for the 90 years of the Hellenic Society for Microbiology was successfully completed, in which we gladly participated through a satellite symposium entitled "Pancreatic Stone Protein to improve the early identification of sepsis".

Prime Biosciences participated in the Panhellenic Conference for the 90 years of the Hellenic Society for Microbiology
READ MORE
26 September 2021

Abionic Webinar - Advancing the diagnosis of sepsis in the intensive care units

 

Real world evidence on the practical implementation of the Pancreatic Stone Protein (PSP) sepsis test was demonstrated at the webinar held by Abionic SA on September 22, 2021. The live discussion on sepsis, chaired by Professor Pedro Póvoa, joined renowned scientists, including Dr. Maria Petraki, MD, Director of ICU - HDU of Mediterraneo Hospital in Athens.

Abionic Webinar - Advancing the diagnosis of sepsis in the intensive care units
READ MORE
15 July 2021

Implementation of a rapid diagnostic test in periprosthetic joint infection (Lyfstone® Calprotectin) in daily practice

 

The European Bone and Joint Infection Society (EBJIS) launched a new model of diagnosing Periprosthetic Joint Infection (PJI). The current approach from EBJIS with the different rule-in criteria and the need for a rule-out tool has been presented in a webinar. 

Implementation of a rapid diagnostic test in periprosthetic joint infection (Lyfstone® Calprotectin) in daily practice
READ MORE
28 May 2021

New data confirms the clinical benefit of PSP for the diagnosis of severe infections in hospitalized adults

 

Critical Care, the top-ranked open access journal in the field of critical care medicine, published the results of a study led by Lausanne University Hospital’s Dr Philippe Eggimann and Bern University Hospital’s Dr Yok-Ai Que this month [1]. The authors analyzed pooled data from five cohorts showing that the Pancreatic stone protein (PSP) biomarker outperforms both C-reactive protein (CRP) and procalcitonin (PCT), two canonical markers of infection, to diagnose severe infection in hospitalized patients.

New data confirms the clinical benefit of PSP for the diagnosis of severe infections in hospitalized adults
READ MORE